Clinical and Translational Radiation Oncology

Papers
(The H4-Index of Clinical and Translational Radiation Oncology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
The technical design and concept of a PET/CT linac for biology-guided radiotherapy36
Evaluation of daily online contour adaptation by radiation therapists for prostate cancer treatment on an MRI-guided linear accelerator26
Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac – Feasibility, workflow data and patient acceptance23
Evaluation of deep learning-based multiparametric MRI oropharyngeal primary tumor auto-segmentation and investigation of input channel effects: Results from a prospective imaging registry23
Feasibility of magnetic resonance guided radiotherapy for the treatment of bladder cancer23
NBTXR3, a first-in-class radioenhancer for pancreatic ductal adenocarcinoma: Report of first patient experience20
CDK 4/6 inhibitors combined with radiotherapy: A review of literature19
Scalp angiosarcoma treated with linear accelerator-based boron neutron capture therapy: A report of two patients19
Radiomic biomarkers of tumor immune biology and immunotherapy response18
Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients17
Whole Brain Irradiation or Stereotactic RadioSurgery for five or more brain metastases (WHOBI-STER): A prospective comparative study of neurocognitive outcomes, level of autonomy in daily activities a16
PIVOTALboost: A phase III randomised controlled trial of prostate and pelvis versus prostate alone radiotherapy with or without prostate boost (CRUK/16/018)16
Dose-dependent volume loss in subcortical deep grey matter structures after cranial radiotherapy16
Selection criteria for early breast cancer patients in the DBCG proton trial – The randomised phase III trial strategy15
Auto-segmentations by convolutional neural network in cervical and anorectal cancer with clinical structure sets as the ground truth14
0.11117815971375